Holders

MOONLAKE IMMUNOTHERAPEUTICS

Q4 2024 13F holders

CUSIP: 61559X104
Type: Equity
Class: CLASS A ORD
Total Reported Value ($000, excl. options)

Manager	Report date	Value ($000)	Shares	Option type